Omeros Corporation
OMER
#6443
Rank
NZ$1.33 B
Marketcap
NZ$18.78
Share price
-1.63%
Change (1 day)
-5.55%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -NZ$0.22 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.28 Billion a decrease over its 2023 earnings that were of -NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.22 Billion-21.9%
2024 -NZ$0.28 Billion9.63%
2023 -NZ$0.25 Billion-9.57%
2022 -NZ$0.28 Billion-30.65%
2021 -NZ$0.4 Billion86.28%
2020 -NZ$0.22 Billion99.45%
2019 -NZ$0.11 Billion-49.91%
2018 -NZ$0.22 Billion190.77%
2017 -NZ$73.49 Million-27.96%
2016 -NZ$0.11 Billion-17.61%
2015 -NZ$0.13 Billion1.88%
2014 -NZ$0.13 Billion87.56%
2013 -NZ$64.8 Million
2011 -NZ$47.45 Million-8.96%
2010 -NZ$52.12 Million45.03%
2009 -NZ$35.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-NZ$16.43 Million-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-NZ$6.69 Million-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
NZ$20.51 B-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA